Both Semaglutide and Mounjaro represent new approaches to managing type 2 diabetes, and increasingly, excess weight. Tirzepatide is a twin agonist that works on multiple hormones involved in metabolism: GLP-1 and GIP. This medication, often considered as a trade name for Semaglutide, operates sim